Dark Forest Capital Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,105
Closed -$16.4K 1263
2025
Q1
$16.4K Sell
14,105
-18,682
-57% -$27.5K ﹤0.01% 1192
2024
Q4
$41.6K Buy
32,787
+13,138
+67% +$33.5K 0.01% 881
2024
Q3
$67K Buy
+19,649
New +$85.5K 0.01% 931
2023
Q4
Sell
-34,920
Closed -$272K 650
2023
Q3
$272K Buy
+34,920
New +$299K 0.02% 937
2022
Q1
Sell
-363
Closed -$10K 1401
2021
Q4
$10K Buy
363
+357
+5,950% +$12.3K ﹤0.01% 922
2021
Q3
$0 Buy
+6
New +$329 ﹤0.01% 1334

Other funds holding EDIT

Dark Forest Capital Management's EDIT Position: Q2 2025 in Review

Dark Forest Capital Management sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 14,105 shares — an estimated $16.4K sold.

Dark Forest Capital Management first reported a position in EDIT in Q3 2021 and held it in 6 quarters. The position peaked at $272K in Q3 2023. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • Dark Forest Capital Management reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 14,105 Editas Medicine shares in Q2 2025, an estimated $16.4K.
  • Dark Forest Capital Management first reported a position in Editas Medicine in Q3 2021 and held it in 6 quarters.
  • Dark Forest Capital Management's Editas Medicine position peaked at $272K in Q3 2023.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.